Clinicians live the problems.
We back the founders solving them.
An invite-only clinician-led angel syndicate backing early-stage healthcare companies with frontline clinical insights.
Most clinicians never access the investments that match their insight
Most clinicians have capital sitting in savings accounts or generic ISAs. No route into high-quality early-stage deal flow. And almost no awareness of the UK tax schemes available to early-stage investors.
Dx Capital exists to change that.
Our Mission
Bridging the gap between clinical expertise and venture capital
The best people to back healthcare innovation are the ones who've lived it. Dx Capital brings together practising clinicians to invest in, advise, and support the companies redefining what healthcare looks like.
Why Dx Capital
The differential advantage
Clinician-led due diligence
We assess what actually matters in healthcare: clinical workflows, adoption risk, and real-world utility.
Off-market deal access
Sourced through NHS, founder, and operator networks before opportunities reach traditional VC.
Active portfolio support
We help companies win NHS pilots, navigate procurement, and hire clinical talent.
Diversified healthcare exposure
Across AI diagnostics, biotech, digital therapeutics, surgical robotics, pharma, and remote monitoring.
What We Back
Where we invest
We invest in pre-seed and seed healthtech, biotech and pharma companies. Individual participation at accessible ticket sizes — invest deal by deal, with flexible terms.
Each member reviews our diligence and makes their own independent investment decisions on a deal-by-deal basis.
Health
Digital health, AI diagnostics, remote monitoring, and clinical decision support tools that transform how care is delivered and experienced.
Biology
Novel therapeutics, precision medicine, and platform technologies at the intersection of biology and engineering — from bench to bedside.
Pharma
Next-generation drug discovery, formulation innovation, and digital-physical pharma models that accelerate time to patient impact.
The Team
Clinicians who invest differently
Dr. Meenakshi Jhala
Co-Founder & Managing Partner
Medical Doctor and NIHR Academic, international speaker and UN delegate. Co-Founder of Tiny Ventures and Editorial Board member of BMJ Innovations. Researcher at Imperial College London and King's College London in digital health.
Dr. Azeem Alam BEM
Co-Founder & Partner
Medical Doctor and clinical product leader. Co-Founder of BiteWorld, reaching 250,000+ clinicians globally. Recipient of the British Empire Medal (BEM). King's Health Partners Board Advisor, scout with EWOR, and IC member at Proximo.
Dr. Jing Ouyang
Co-Founder & Partner
Medical Doctor and Co-Founder of Patchwork Health, a health tech scale up that works with 100+ NHS Trusts. He is the host of the OOP podcast and mentors healthtech founders through BiteLabs, UCL GBSH, and the NHSE CEP.
Membership
Who we're looking for
Membership of Dx Capital is by application and invite-only.
All applications are reviewed by our founding team.
Healthcare professionals and other investors with domain expertise in healthtech, biotech or pharma
High net worth individuals or self-certified sophisticated investors (as defined by FCA regulations)
Those with an interest in supporting early-stage founders solving real problems in healthcare
Next steps
What happens if you are shortlisted
Receive curated deal flow with full clinical and financial context
Invitations to private investor briefings ahead of each deal
Access to the Dx Capital angel investor community
Join us
Apply to the clinician-led angel syndicate shaping the future of healthtech, biotech and pharma
Connect with founders and clinicians redefining what healthcare looks like.
Join Us
Join the waitlist
Register your interest in joining the Dx Capital angel network.
Contact Us
[email protected]Risk Warning: Dx Capital is a private investment community and does not provide financial advice. Investing in early-stage companies involves significant risk including total loss of capital. Any reference to UK tax schemes is for informational purposes only and subject to individual circumstances. Each member makes their own independent investment decisions. Please seek independent financial advice before making any investment decisions.
We use cookies to improve your experience and analyse site usage. By continuing, you agree to our Cookie Policy.